Czechia, Jan. 6 -- Czechia based Janssen-Cilag s.r.o. has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Supplies of the drug - TREMFYA 2025. The value of the contract is worth 1317800000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....